Ӱҵ

Corporate Information

Company Name Ӱҵ.
Date Established December 6, 1941
Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
Telephone 81-3-3817-3700
Representatives Haruo Naito, Representative Corporate Officer and CEO
Yasushi Okada, Representative Corporate Officer
Keisuke Naito, Representative Corporate Officer and Executive Vice President
Capital 44,986 million Yen (as of March 31, 2024)
Scope of Business Research and development, manufacture, sale and import and export of pharmaceuticals
Organization Chart
Employees Consolidated : 11,067
Non-Consolidated : 2,984 (as of March 31, 2024)
Production Plants Kawashima Industrial Park (Gifu Prefecture)
Kashima Plant (Ibaraki Prefecture)
ӰҵManufacturing Ltd. (U.K.)
ӰҵChina Inc. Suzhou Plant (China)
Ӱҵ(Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China)
ӰҵPharmaceuticals India Pvt. Ltd. (India), etc.
Laboratories Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Industrial Park (Gifu Prefecture)
Kashima Business Office (Ibaraki Prefecture)
Kobe Research Laboratories (Hyogo Prefecture)
ӰҵCenter for Genetics Guided Dementia Discovery (G2D2) (U.S.A.)
Exton Site (U.S.A.)
Hatfield Research Institute (U.K.), etc.
Overseas Sales Offices ӰҵInc. (U.S.A.)
ӰҵLtd. (U.K.)
ӰҵGmbH (Germany)
ӰҵS.A.S. (France)
ӰҵChina Inc. (China)
ӰҵKorea Inc. (South Korea), etc.

Stock Information

Fiscal Year End March 31
Record Date for Dividend Year-end dividend - March 31
Interim dividend - September 30
Annual Shareholders' Meeting June
Stock Exchange Listings Tokyo Stock Exchange
Stock Trading Unit 100 shares
Ticker Code 4523